ALFA Filings
Every announcement, straight from the exchange
Every Genesys International Corporation capital structure change announcement on NSE and BSE, newest first, each with its own page.
Time
10 announcements
Genesys International Corporation Limited has allotted 2,50,74,226 equity shares following a Rights Issue. This allotment increases the company's paid-up share capital to Rs. 33.43 Crore.
Genesys International allotted 2.51 crore shares at ₹50 per share through a rights issue. This capital infusion totals ₹125.37 Crore.
Genesys International will raise funds via a rights issue of 25.07 million equity shares at Rs.50 each. The issue ratio is 3:5 with a record date of August 6, 2026.
Genesys International approved a rights issue of equity shares. The total issue amount will not exceed ₹139.3 Crore.
Genesys International approved increasing its authorized share capital to ₹45 Crore. This regulatory change enables future equity issuances and provides significant headroom for capital expansion.
Genesys International Corporation Limited approved increasing its authorized share capital from 5,45,00,000 to 9,00,00,000 equity shares of ₹5 each. The move aims to facilitate future business expansion and operational requirements. A shareholder meeting is scheduled for May 28, 2026, to finalize the alteration.
Genesys International Corporation Ltd has approved increasing its Authorized Share Capital from ₹27.25 Crore to ₹45.00 Crore. This change involves an amendment to the Memorandum of Association and is subject to shareholder approval via postal ballot. This expansion of capital limits provides the company with headroom for future equity issuances.
Genesys International Corporation Limited has scheduled a board meeting for April 23, 2026, to consider increasing its authorized share capital. The company's trading window remains closed until June 1, 2026, in accordance with SEBI PIT Regulations.
Genesys International Corporation Limited has scheduled a board meeting for April 23, 2026, to consider an increase in its authorized capital. The trading window for designated persons remains closed from April 1 until June 1, 2026.
Genesys International Corporation Ltd has scheduled a board meeting for April 23, 2026, to approve an increase in authorized share capital. The board will also consider a postal ballot notice and an amendment to the company's Memorandum of Association. This administrative step enables the company to issue new shares in the future.